Gleason sum upgrading (GSU) is common in patients with organ-confined prostate cancer. Studies in 2010 have identified GSU predictors and examined the role of GSU in patients with prostate cancer, but several clinical applications for GSU have been suggested-has its clinical importance in daily practice been inflated?
PROSTATE CANCER IN 2010 GSU: misclassification or biological progression?
Suardi N
2011-01-01
Abstract
Gleason sum upgrading (GSU) is common in patients with organ-confined prostate cancer. Studies in 2010 have identified GSU predictors and examined the role of GSU in patients with prostate cancer, but several clinical applications for GSU have been suggested-has its clinical importance in daily practice been inflated?File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.